BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 335762)

  • 1. An in vivo model for testing inhibition of arginine-induced insulin and glucagon release by somatostatin analogs.
    Gordin A; Meyers C; Arimura A; Coy DH; Schally AV
    Acta Endocrinol (Copenh); 1977 Dec; 86(4):833-41. PubMed ID: 335762
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Selective effect of some somatostatin analogs on glucagon as opposed to insulin release in rats in vivo.
    Lins PE; Efendić S; Meyers CA; Coy DH; Schally A; Luft R
    Metabolism; 1980 Aug; 29(8):728-31. PubMed ID: 6105610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological activity of somatostatin and somatostatin analogs on inhibtion of arginine-induced insulin and glucagon release in the rat.
    Brown M; Rivier J; Vale W
    Endocrinology; 1976 Feb; 98(2):336-43. PubMed ID: 813991
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-selective inhibition of basal glucagon release by [D-Cys14]-analogues of somatostatin in the rat.
    Märki F; Kamber B; Rink H; Sieber P
    J Endocrinol; 1979 Jun; 81(3):315-23. PubMed ID: 469462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of highly potent octapeptide analogs of somatostatin on growth hormone, insulin and glucagon release.
    Karashima T; Cai RZ; Schally AV
    Life Sci; 1987 Aug; 41(8):1011-9. PubMed ID: 2886886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of somatostatin and two of its analogues on basal and arginine-stimulated insulin and glucagon secretion in the dog.
    Buchs A; Märki F; Keller U
    Regul Pept; 1982 Aug; 4(3):117-26. PubMed ID: 6127755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of somatostatin and a glucagon-specific analog on glucose homeostasis during arginine infusion.
    Lien EL
    Metabolism; 1978 Sep; 27(9):1095-100. PubMed ID: 682972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Somatostatin: analogs with selected biological activities.
    Brown M; Rivier J; Vale W
    Science; 1977 Jun; 196(4297):1467-9. PubMed ID: 867045
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of glucagon and insulin secretion by somatostatin in the rat pancreas perfused in situ.
    Johnson DG; Ensinck JW; Koerker D; Palmer J; Goodner CJ
    Endocrinology; 1975 Feb; 96(2):370-4. PubMed ID: 1089535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of galanin on arginine-stimulated pancreatic hormone release from isolated perifused rat islets.
    Tajiri Y; Sako Y; Umeda F; Hisatomi A; Nawata H
    Horm Metab Res; 1990 Jan; 22(1):1-6. PubMed ID: 1689687
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of a paracrine role for pancreatic somatostatin in vivo.
    Taborsky GJ
    Am J Physiol; 1983 Dec; 245(6):E598-603. PubMed ID: 6140853
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of neurotensin on insulin, glucagon, and somatostatin release from isolated pancreatic islets.
    Dolais-Kitabgi J; Kitabgi P; Brazeau P; Freychet P
    Endocrinology; 1979 Jul; 105(1):256-60. PubMed ID: 376297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin, insulin and glucagon secretion by the perfused pancreas from the cysteamine-treated rat.
    Silvestre RA; Miralles P; Moreno P; Villanueva ML; Marco J
    Biochem Biophys Res Commun; 1986 Feb; 134(3):1291-7. PubMed ID: 2868720
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibitory action of somatostatin on pancreatic alpha and beta cell function.
    Leblanc H; Anderson JR; Sigel MB; Yen SS
    J Clin Endocrinol Metab; 1975 Apr; 40(4):568-72. PubMed ID: 1092707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of alpha- and beta-cell secretory responses in islets isolated with collagenase and in the isolated perfused pancreas of rats.
    Norfleet WT; Pagliara AS; Haymond MW; Matschinsky F
    Diabetes; 1975 Nov; 24(11):961-70. PubMed ID: 171190
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissociated effects of somatostatin analogs on arginine-induced insulin, glucagon and growth hormone release in acromegalic patients.
    Wajchenberg BL; Cesar FP; Leme CE; Borghi VC; Souza VC; Souza IT; Neto DG; Germek OA; Coy DH; Comaru-Schally AM
    Horm Metab Res; 1983 Oct; 15(10):471-4. PubMed ID: 6139329
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glucagon mediates arginine-induced somatostatin secretion from isolated rat pancreatic islets.
    Vonen B; Florholmen J; Malm D; Torjessen P; Burhol PG
    Scand J Clin Lab Invest; 1992 Apr; 52(2):107-12. PubMed ID: 1350374
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pancreastatin and islet hormone release.
    Efendić S; Tatemoto K; Mutt V; Quan C; Chang D; Ostenson CG
    Proc Natl Acad Sci U S A; 1987 Oct; 84(20):7257-60. PubMed ID: 2890162
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential effects of somatostatin analogues on alpha- and beta-cells of the pancreas.
    Taborsky GJ; Smith PH; Porte D
    Am J Physiol; 1979 Feb; 236(2):E123-8. PubMed ID: 369388
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of imidazoline derivative RX871024 on insulin, glucagon, and somatostatin secretion from isolated perfused rat pancreas.
    Efanova IB; Zaitsev SV; Efanov AM; Ostenson C; Raap A; Mest H; Berggren P; Efendi
    Biochem Biophys Res Commun; 1998 Nov; 252(1):162-5. PubMed ID: 9813163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.